Stockreport

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy [Yahoo! Finance]

Kodiak Sciences Inc  (KOD) 
Last kodiak sciences inc earnings: 11/12 05:30 am Check Earnings Report
PDF GLOW2 study design mirrors GLOW1 study, which met primary endpoint and all key secondary endpoints with high statistical significance PALO ALTO, Calif. March 10, 2025 [Read more]